Pacific Biosciences
Pacific Biosciences of California, Inc. (PACB) specializes in developing and manufacturing innovative sequencing technologies and systems to provide comprehensive genomic insights. It generates revenue by selling its sequencing instruments, consumables, and related services to research institutions, healthcare providers, and commercial organizations interested in genomic analysis.
The ten most recent trades of Pacific Biosciences in all the Ark ETFs ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Jan 07, 2025 | Buy | $99,219 | 0.38% | 0.01% |
Jan 07, 2025 | Buy | $171,614 | 0.39% | 0.00% |
Jan 06, 2025 | Buy | $287,849 | 1.19% | 0.03% |
Jan 06, 2025 | Buy | $494,452 | 1.21% | 0.01% |
Dec 20, 2024 | Buy | $854,094 | 2.18% | 0.01% |
Dec 20, 2024 | Buy | $136,428 | 0.58% | 0.01% |
Dec 18, 2024 | Buy | $446,634 | 1.16% | 0.01% |
Dec 18, 2024 | Buy | $258,631 | 1.12% | 0.02% |
Dec 17, 2024 | Buy | $438,626 | 1.08% | 0.01% |
Dec 17, 2024 | Buy | $255,301 | 1.05% | 0.02% |